Ajouter aux favoris   Ajouter cette page à mon bookmark --- SOCIAL BOOKMARKING --- Digg Furl del.icio.us Netscape

Datamonitor's OTC Pharmaceuticals in Japan industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of the industry’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of the industry

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer and/or brand

* Also features market breakdown by distribution channel

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 3
1.1 Market Definition 3
1.2 Research Highlights 3
1.3 Market Analysis 3
CHAPTER 2 Market Value 3
CHAPTER 3 Market Segmentation I 3
CHAPTER 4 Market Segmentation II 3
CHAPTER 5 Market Share 3
CHAPTER 6 Five Forces Analysis 3
6.1 Summary 3
6.2 Buyer Power 3
6.3 Supplier Power 3
6.4 New Entrants 3
6.5 Substitutes 3
6.6 Rivalry 3
CHAPTER 7 Leading Companies 3
7.1 Pfizer Inc 3
7.2 Novartis AG 3
7.3 Wyeth 3
CHAPTER 8 Distribution 3
CHAPTER 9 Market Forecasts 3
9.1 Market Value Forecast 3
CHAPTER 10 Macroeconomic Indicators 3
CHAPTER 11 Appendix 3
11.1 Methodology 3
11.2 Industry Associations 3
11.3 Related Datamonitor Research 3

LIST OF TABLES
Table 1: Japan OTC Pharmaceuticals Market Value: $ billion, 2003-2007 3
Table 2: Japan OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 3
Table 3: Japan OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 3
Table 4: Japan OTC Pharmaceuticals Market Share: % Share, by Value, 2007 3
Table 5: Key Facts: Pfizer Inc 3
Table 6: Key Financials: Pfizer Inc 3
Table 7: Key Facts: Novartis AG 3
Table 8: Key Financials: Novartis AG 3
Table 9: Key Facts: Wyeth 3
Table 10: Key Financials: Wyeth 3
Table 11: Japan OTC Pharmaceuticals Distribution: % Share, by Value, 2007 3
Table 12: Japan OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 3
Table 13: Japan Size of Population (million) , 2003-2007 3
Table 14: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007 3
Table 15: Japan Exchange Rate, 2003 3